Literature DB >> 8748286

Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells.

O Vapalahti1, A Lundkvist, H Kallio-Kokko, K Paukku, I Julkunen, H Lankinen, A Vaheri.   

Abstract

Puumala virus (PUU) is a member of the genus Hantavirus in the family Bunyaviridae and the causative agent of nephropathia epidemica, a European form of hemorrhagic fever with renal syndrome. Sera of nephropathia epidemica patients react specifically with PUU nucleocapsid (N) protein. In order to safely provide large quantities of antigen for diagnostic purposes, PUU Sotkamo strain N protein was expressed by using the baculovirus system in Sf9 insect cells to up to 30 to 50% of the total cellular protein. The recombinant N protein (bac-PUU-N) was solubilized with 6 M urea, dialyzed, and purified by anion-exchange liquid chromatography. In an immunoglobulin M mu-capture assay purified and unpurified bac-PUU-N antigen showed identical results compared with the results of a similar assay based on native PUU antigen grown in Vero E6 cells. An immunoglobulin G monoclonal antibody-capture assay based on unpurified bac-PUU-N also showed results identical to those of an assay with native PUU-N antigen. Moreover, a panel of monoclonal antibodies reactive with eight different epitopes showed identical reactivity patterns with both natural and bac-PUU-N antigen, while two epitopes in PUU-N expressed as a fusion protein in Escherichia coli were not recognized. Puumala hantavirus N protein expressed by the baculovirus system offers a safe and inexpensive source of specific antigen for large-scale diagnostic and seroepidemiological purposes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8748286      PMCID: PMC228743          DOI: 10.1128/jcm.34.1.119-125.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  49 in total

1.  Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide.

Authors:  D C Tessier; D Y Thomas; H E Khouri; F Laliberté; T Vernet
Journal:  Gene       Date:  1991-02-15       Impact factor: 3.688

2.  Comparison of the deduced gene products of the L, M and S genome segments of hantaviruses.

Authors:  D Antic; C Y Kang; K Spik; C Schmaljohn; O Vapalahti; A Vaheri
Journal:  Virus Res       Date:  1992-06       Impact factor: 3.303

3.  Molecular characterization of the RNA S segment of nephropathia epidemica virus strain Hällnäs B1.

Authors:  R Stohwasser; L B Giebel; L Zöller; E K Bautz; G Darai
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

4.  Genome structure and variability of a virus causing hantavirus pulmonary syndrome.

Authors:  C F Spiropoulou; S Morzunov; H Feldmann; A Sanchez; C J Peters; S T Nichol
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

5.  A novel mu-capture enzyme-linked immunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome.

Authors:  L G Zöller; S Yang; P Gött; E K Bautz; G Darai
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

6.  Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response.

Authors:  O Vapalahti; H Kallio-Kokko; A Närvänen; I Julkunen; A Lundkvist; A Plyusnin; H Lehväslaiho; M Brummer-Korvenkontio; A Vaheri; H Lankinen
Journal:  J Med Virol       Date:  1995-08       Impact factor: 2.327

7.  Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome.

Authors:  H Feldmann; A Sanchez; S Morzunov; C F Spiropoulou; P E Rollin; T G Ksiazek; C J Peters; S T Nichol
Journal:  Virus Res       Date:  1993-12       Impact factor: 3.303

8.  Genetic variation of wild Puumala viruses within the serotype, local rodent populations and individual animal.

Authors:  A Plyusnin; O Vapalahti; H Lehväslaiho; N Apekina; T Mikhailova; I Gavrilovskaya; J Laakkonen; J Niemimaa; H Henttonen; M Brummer-Korvenkontio
Journal:  Virus Res       Date:  1995-09       Impact factor: 3.303

9.  Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection.

Authors:  M Brummer-Korvenkontio; A Vaheri; T Hovi; C H von Bonsdorff; J Vuorimies; T Manni; K Penttinen; N Oker-Blom; J Lähdevirta
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

10.  Sequences of wild Puumala virus genes show a correlation of genetic variation with geographic origin of the strains.

Authors:  A Plyusnin; O Vapalahti; K Ulfves; H Lehväslaiho; N Apekina; I Gavrilovskaya; V Blinov; A Vaheri
Journal:  J Gen Virol       Date:  1994-02       Impact factor: 3.891

View more
  39 in total

1.  Diagnostic potential of puumala virus nucleocapsid protein expressed in Drosophila melanogaster cells.

Authors:  K Brus Sjölander; I Golovljova; A Plyusnin; A Lundkvist
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Smoking is associated with aggravated kidney injury in Puumala hantavirus-induced haemorrhagic fever with renal syndrome.

Authors:  Laura Tervo; Satu Mäkelä; Jaana Syrjänen; Reetta Huttunen; Arja Rimpelä; Heini Huhtala; Olli Vapalahti; Antti Vaheri; Jukka Mustonen
Journal:  Nephrol Dial Transplant       Date:  2015-07-05       Impact factor: 5.992

3.  Competitive Homogeneous Immunoassay for Rapid Serodiagnosis of Hantavirus Disease.

Authors:  Satu Hepojoki; Juuso Rusanen; Jussi Hepojoki; Visa Nurmi; Antti Vaheri; Åke Lundkvist; Klaus Hedman; Olli Vapalahti
Journal:  J Clin Microbiol       Date:  2015-05-13       Impact factor: 5.948

4.  Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins.

Authors:  Helga Meisel; Anne Wolbert; Ausra Razanskiene; Andreas Marg; Andris Kazaks; Kestutis Sasnauskas; Georg Pauli; Rainer Ulrich; Detlev H Krüger
Journal:  Clin Vaccine Immunol       Date:  2006-10-04

5.  Hormonal deficiencies during and after Puumala hantavirus infection.

Authors:  S Mäkelä; P Jaatinen; M Miettinen; J Salmi; I Ala-Houhala; H Huhtala; M Hurme; I Pörsti; A Vaheri; J Mustonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-16       Impact factor: 3.267

Review 6.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

7.  Antigenic characterization of Hantaan and Seoul virus nucleocapsid proteins expressed by recombinant baculovirus: application of a truncated protein, lacking an antigenic region common to the two viruses, as a serotyping antigen.

Authors:  M Morii; K Yoshimatsu; J Arikawa; G Zhou; H Kariwa; I Takashima
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations.

Authors:  Tuula K Outinen; Satu M Mäkelä; Ilpo O Ala-Houhala; Heini Sa Huhtala; Mikko Hurme; Antti S Paakkala; Ilkka H Pörsti; Jaana T Syrjänen; Jukka T Mustonen
Journal:  BMC Infect Dis       Date:  2010-05-25       Impact factor: 3.090

9.  Expression of the nucleoprotein of the Puumala virus from the recombinant Semliki Forest virus replicon: characterization and use as a potential diagnostic tool.

Authors:  A Billecocq; D Coudrier; F Boué; B Combes; H Zeller; M Artois; M Bouloy
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

10.  Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses.

Authors:  Sabine Lederer; Erik Lattwein; Merle Hanke; Karen Sonnenberg; Winfried Stoecker; Åke Lundkvist; Antti Vaheri; Olli Vapalahti; Paul K S Chan; Heinz Feldmann; Daryl Dick; Jonas Schmidt-Chanasit; Paula Padula; Pablo A Vial; Raluca Panculescu-Gatej; Cornelia Ceianu; Paul Heyman; Tatjana Avšič-Županc; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2013-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.